Regencell Bioscience Holdings (RGC) Current Leases (2022 - 2025)

Regencell Bioscience Holdings has reported Current Leases for 4 years, with the latest figure at $258124.0 in Q4 2025.

• For the quarter ending Q4 2025, Current Leases changed N/A year-over-year to $258124.0; the trailing twelve-month figure through Dec 2025 stood at $258124.0 (changed N/A YoY), and the FY2025 full-year result was $312780.0, up 422.98% from the prior year.
• Current Leases for Q4 2025 stood at $258124.0, down from $312780.0 in the prior quarter.
• The five-year high for Current Leases was $438263.0 in Q2 2023, with the low at $59807.0 in Q2 2024.
• Historically, Current Leases has averaged $295992.2 across 4 years, with a median of $312780.0 in 2025.
• Annual changes were most pronounced in 2024 — Current Leases slumped 86.35% — and 2025, when it surged 422.98%.
• Regencell Bioscience Holdings' Current Leases stood at $410987.0 in 2022, then grew by 6.64% to $438263.0 in 2023, then tumbled by 86.35% to $59807.0 in 2024, then soared by 331.59% to $258124.0 in 2025.
• The last three Current Leases figures came in at $258124.0 (Q4 2025), $312780.0 (Q2 2025), and $59807.0 (Q2 2024), per Business Quant data.